We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Fusion Antibodies Announces Appointment of New CEO

News   Nov 13, 2006

 
Fusion Antibodies Announces Appointment of New CEO
 
 
Advertisement
 

RELATED ARTICLES

Portable 90-Minute COVID-19 Test CovidNudge Matches Labs for Accuracy

News

Since the emergence of the novel coronavirus SARS-CoV-2, scientists, physicians and key workers have all been calling for more rapid diagnostic testing. A new study from Imperial College London details a device that can give test results in just 90 minutes.

READ MORE

Study of Over 1 Million People Suggests Blood Type O May Protect Against COVID-19

News

In June, Technology Networks reported on some of the initial findings from personal genomics and biotechnology company 23andMe's COVID-19 genetic study. These results lent further evidence to earlier suggestions that an individual's blood type – determined by a gene known as ABO – may be associated with COVID-19 susceptibility. Now, 23andMe scientists have published results from the first four months of the study which has collected data from over 1 million research participants.

READ MORE

Phase 3 Clinical Trial of Belimumab for Lupus Nephritis Reports Positive Results

News

Results from the largest Phase 3 lupus nephritis clinical trial ever conducted were announced, September 16. The study, found positive results of the efficacy and safety of the drug belimumab in patients with active lupus nephritis, a condition that causes inflammation in the kidneys of patients with systemic lupus erythematosus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE